Has Vikas Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,748 in general payments to Vikas Patel, MD across 37 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vikas Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vikas Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vikas Patel, MD

Dermatology · Raleigh, NCNPI 1407935083

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,080 of the $1,748 with a category attached, or 61.7%. 9 manufacturers reported payments, led by Johnson & Johnson at 34.4% of the total. Reporting peaked in 2019 at $730 and has fallen 71.5% since, to $208 in 2025. That places this record below the midpoint for dermatology clinicians in NC, where the typical reported total is $2,057.

$1,748in general payments, 2019–2025

Across 37 payments — averaging $47.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$602
Merz North America, Inc.$570
Pfizer$188
Ortho Dermatologics, A Division Of Bausch Health US, LLC$128
Abbott$92
Galderma Laboratories, L.p.$71
plus $98 from 3 others

$109,875in research payments, 2019–2025

Across 48 payments — averaging $2289.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sun Pharmaceutical Industries Inc.$92K
Galderma Laboratories, L.p.$18K

What the payments were for

Food & beverage$1,08062%
Education$66938%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	7	$602
Merz North America, Inc.	7	$570
Pfizer	10	$188
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$128
Abbott	1	$92
Galderma Laboratories, L.p.	5	$71
AbbVie	3	$58
Verrica Pharmaceuticals Inc.	1	$25
Dermavant Sciences, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SILIQ$125

How this compares

$1,748 in reported general payments places this provider in the 45th percentile of 475 dermatology providers in North Carolina.

See all dermatology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$129,620

Medicare patients

491

Services billed

2,130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	12	$81,410
Calcipotriene	23	$4,334
Clobetasol Propionate	79	$3,152
Metronidazole	55	$3,089
Acitretin	12	$2,078
Fluocinonide	40	$1,700
Ketoconazole	96	$1,404
Clindamycin Phosphate	24	$1,029
Fluocinolone Acetonide	17	$900
Doxycycline Hyclate	32	$785
ValacyclovirValacyclovir Hcl	12	$652
Nystatin	15	$458
Triamcinolone Acetonide	58	$445
Econazole Nitrate	11	$355
Fluconazole	33	$302

Paid to pharmacies, not to this prescriber.

Other dermatology in Raleigh

Rebekah OylerRaleigh$72K
Beth Schulz-ButulisRaleigh$18K
Steven FeldmanWinston Salem$3.4M
Nicole SeminaraHuntersville$1.4M
Andrew LeeElkin$702K
Christopher SayedChapel Hill$690K
William HooverConcord$594K
Patrick McElgunnCharlotte$565K
George MagelHickory$554K
Muneeb ShahClinton$451K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →